NCT07400926Recruiting
Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg
Clinical In-use Observational Trial to Evaluate the Updated Inserter for the Travoprost Intracameral Implant 75 mcg
Source: ClinicalTrials.gov · Last updated 27 Feb 2026
Brief summary (registry, in English)
Clinical in-use observational trial to evaluate the updated inserter for the Travoprost Intracameral implant using the updated inserter (Model G2-TRIO)
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 30 (estimated)
- First submitted
- 3 Feb 2026
- Start date
- 17 Dec 2025
- Primary completion date
- Jun 2026
- Lead sponsor
- Glaukos Corporation
- Diseases
- Glaucoma, High blood pressure
- NCT number
- NCT07400926
What you commit to
- Study type: Observational
- Planned participants: 30
- From 17 Dec 2025 to the primary completion date, Jun 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Subject who is breast-feeding or pregnant
Who the study is looking for
- Diagnosis of Open-angle glaucoma
- 18 years of age or older
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| - Coordinator of this site? Confirm its status | Kenosha | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.